Ara
Toplam kayıt 8, listelenen: 1-8
Is Activated Factor Vii Associated with Retinal Vein Occlusion?
(British Med Journal Publ Group, 2001)
Aim-To determine whether a newly identified thrombophilia factor, activated factor VII (FVIIa), is associated with retinal vein occlusion (RVO). Methods-54 consecutive cases with RVO seen between March and September 1999 ...
Efficacy And Complications Of Dose Increments Of Botulinum Toxin-A In The Treatment Of Horizontal Comitant Strabismus
(Royal Coll Ophthalmologists, 2000)
Purpose To investigate the efficacy and complications associated with dose increments of botulinum toxin-A (BTA) for comitant horizontal strabismus patients. Methods Twenty-five esotropic (ET) and 45 exotropic (XT) patients ...
Subretinal Fluid Levels of Topical, Oral, and Combined Administered Ciprofloxacin in Humans
(British Med Journal Publ Group, 2000)
Aims-To investigate the subretinal fluid (SRF) penetration of ciprofloxacin following topical, oral, and combined administration. Methods-34 patients undergoing conventional retinal reattachment surgery were randomly ...
The Sensitivity And Specificity Of 0.5% Apraclonidine In The Diagnosis Of Oculosympathetic Paresis
(Bmj Publishing Group, 2005)
Aims: To evaluate the sensitivity and specificity of 0.5% apraclonidine test in the diagnosis of oculosympathetic paresis (OSP). Method: Apraclonidine ( 0.5%) was administered to 31 eyes, nine with a diagnosis of Horner ...
Mean Intraocular Pressure and Progression Based on Corneal Thickness in Patients with Ocular Hypertension
(Nature Publishing Group, 2009)
Purpose To determine the incidence of glaucomatous progression at mean intraocular pressure (IOP) levels in patients with ocular hypertension (OHT). Methods A retrospective, multicentre, cohort analysis of 230 OHT patients ...
Diurnal Iop Control With Bimatoprost Versus Latanoprost in Exfoliative Glaucoma: a Crossover, Observer-Masked, Three Centre Study
(BMJ, 2007)
Aim: To evaluate the diurnal intraocular pressure (IOP) control and safety of bimatoprost versus latanoprost in exfoliative glaucoma (XFG). Methods: One eye of 129 consecutive patients with XFG (mean (SD) age 66.5 (8.3) ...